Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Deleted Lung cancer and related topics including MedlinePlus Genetics from the study's topics section.
    Difference
    0.2%
    Check dated 2026-01-06T22:45:58.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added related topics sections for Lung cancer and MedlinePlus Genetics to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T13:23:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    - The Locations section reorganizes location details from separate state blocks (Maryland, New York, Pennsylvania) into a single consolidated Locations section; revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T09:42:39.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.3.1; removed Lung cancer and related topics (MedlinePlus Genetics) and Revision: v3.2.0.
    Difference
    0.2%
    Check dated 2025-11-24T14:44:19.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Lung cancer and related topics were added to the related topics section, and a government funding notice was removed. These changes affect navigation and contextual information rather than the core study details.
    Difference
    0.6%
    Check dated 2025-11-17T07:10:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.